About The Medical Condition MDL17,043

ClusterMed

Find the definition of the medical term MDL17,043. MDL17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

MDL17,043

MDL17,043 Medical Condition Defined & Explained
MDL17,043 Medical Condition

What's The Definition Of The Medical Condition MDL17,043?

1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day

  • Celiase ‐ Streptococcal fibrinolysin . An enzyme produced by hemolytic…
  • Border, Brush ‐ Minute projections of cell membranes which greatly increase the…
  • Specificities, Species ‐ Restriction of a characteristic or response to the members of…
  • Cochlear Nerve Disorders ‐ Diseases of the vestibular and/or cochlear (acoustic) nerves,…
  • STLV-1 ‐ A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2, closely related to…
  • Thyroid Glands ‐ A highly vascular endocrine gland consisting of two lobes, one…
  • Nerves, Sural ‐ A branch of the tibial nerve which supplies sensory innervation…
  • Leukemia Virus, Cattle ‐ The type species of DELTARETROVIRUS that causes a form of bovine…
  • Mother-Child Relationships ‐ Interaction between the mother and…
  • Porphyria ‐ A group of disorders characterized by the excessive production…